Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Merck to acquire Imago BioSciences in deal worth $1.35bn

The agreement includes lead candidate, bomedemstat, for myeloproliferative neoplasms

- PMLiVE

Cancer Research Horizons and Newcastle University extend alliance with Astex

The agreement will extend the current alliance between the three parties by a further five years

- PMLiVE

ICR and The Royal Marsden reveal plans to ‘disrupt’ cancer ecosystems

The researchers aim to double survival for people with advanced cancer within a decade

- PMLiVE

WHO launches R&D efforts to identify pathogens that could cause future pandemics

Over 300 scientists will convene to discuss over 25 virus and bacteria, including ‘Disease X’

- PMLiVE

Actionable Insights for Medical Affairs: Elusive or Within Reach?

Plato was right: Necessity is the mother of invention, and — in the case of Medical Affairs departments — the driving force behind their creation was the federally mandated separation...

Medscape Medical Affairs

Centering Caregivers

How Pharma can (and why they should) help bring caregivers to the forefront

Impetus Digital

- PMLiVE

C-Suite keystones

By Brian D Smith

- PMLiVE

European MPs call for urgent action against antimicrobial resistance

It is estimated that AMR could lead to as many as ten million deaths each year by 2050

- PMLiVE

BeiGene’s Brukinsa receives EC approval for chronic lymphocytic leukaemia

The drug showed better results than Imbruvica, a current standard of care treatment

regeneron headquarters

Regeneron and CytomX partner to create conditional bispecific cancer therapies

CytomX is set to receive an upfront payment of $30m as well as milestones of up to $2bn

- PMLiVE

Sanofi’s Enjaymo receives EC approval for rare autoimmune haemolytic anaemia

Cold agglutinin disease affects around 12,000 people in the US, Europe and Japan

- PMLiVE

Infex doses first patients in Pseudomonas aeruginosa phase 1 study

Pa is a leading cause of non-cystic fibrosis bronchiectasis exacerbations

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links